|Written by GSCR Staff|
|Tuesday, 18 November 2014 06:56|
In yesterday’s Goldman Guide we made a top ten list of market thoughts that included the need to start looking for potential turn around stocks from 2014, possibly in tech or consumer discretionary.
There were plenty of potential candidates from our Market Monitor picks for this year, but one consumer discretionary stock stood out from the crowd even in the fickle apparel sector.
We featured Cherokee, Inc. (NASDAQ – CHKE - $17.59) in early August. The stock is not a total loser, and in fact is up just over 1% since our initial feature. With that said, we think that the measly 1% is not enough.
Right on queue we mentioned that apparel in general could have good uptick if we get an early winter. Well, unfortunately, it’s here! Cherokee has some brands and products that could meet increased demand. The Company markets, manages, and licenses fashion and lifestyle brands that it owns or represents for apparel, footwear, home, and accessories worldwide. The Company owns Cherokee, Sideout, Liz Lange, Sideout Sport, Carole Little, Saint Tropez-West, Chorus Line, All That Jazz, Uniform, Completely Me by Liz Lange, Tony Hawk, Hawk, and other brands. It also assists other brand-owners, companies, wholesalers, and retailers in identifying opportunities as a licensee or licensor for their brands or stores.
One item we emphasized in the Guide was looking for EPS rebounds. The Company beat estimates for FY14Q4 by nearly 200%, FY15Q1 by nearly 75%, and missed by just a penny for FY15Q2. The Company is expected to bring in $1.10 per share for FY15, up 35% from FY14. This puts the forward 12-month P/E under 15, a few points under the trailing 12-month P/E currently near 18.
Additionally, the Company has had an outstanding streak of expanding existing brands both through acquisition and organic growth. Recently, the Company announced three new partnerships for its ále by Alessandra Brand that include Oxford Ophthalmic, Physician Endorsed and Esquire Footwear, that will debut lines of hats, totes and casual footwear, Oxford Ophthalmic’s eyewear, and resort, spa, and cruise line collections with products designed for golf, tennis, yachting and sailing clubs.
With an impressive operating margin of 47% versus the industry average of 4%, and over $4 million in cash on hand, Cherokee is poised to maximize future ventures given this efficiency. We think 2015 expansion lead to a great 2015 for CHKE. Look for a price of just over $22.
Have a great day!
Disclosure: Goldman Small Cap Research analysts are neither long nor short these shares but may elect to purchase the stock within the next 48 hours.
This Market Monitor blog was prepared for informational purposes only. Goldman Small Cap Research, (a division of Two Triangle Consulting Group, LLC) produces research via two formats: Goldman Select Research, which typically highlights small cap companies, and Goldman Opportunity Research, which features micro cap companies in a sponsored research format. Thus, the Select product reflects the Firm’s internally generated stock ideas while the Opportunity product reflects sponsored research reports.
Goldman Small Cap Research is not affiliated in any way with Goldman Sachs & Co.
It is important to note that while we may track performance separately, we utilize the same coverage criteria in determining coverage of all stocks in both research formats. Please view the company’s individual disclosures for each engagement, which can be found in each company-specific report. All information contained in this blog, newsletter and in our reports were provided by the Companies or generated from our own due diligence. Our analysts are responsible only to the public, and are paid in advance to eliminate pecuniary interests, retain editorial control, and ensure independence. Analysts are compensated on a per report basis and not on the basis of his/her recommendations.
The information used and statements of fact made have been obtained from sources considered reliable but we neither guarantee nor represent the completeness or accuracy. Goldman Small Cap Research did not make an independent investigation or inquiry as to the accuracy of any information provided by the Company, or other firms. Goldman Small Cap Research relied solely upon information provided by the Company through its filings, press releases, presentations, and through its own internal due diligence for accuracy and completeness. Such information and the opinions expressed are subject to change without notice. A Goldman Small Cap Research blog, report, note, or newsletter is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed.
This blog does not take into account the investment objectives, financial situation, or particular needs of any particular person. This blog does not provide all information material to an investor’s decision about whether or not to make any investment. Any discussion of risks in this presentation is not a disclosure of all risks or a complete discussion of the risks mentioned. Neither Goldman Small Cap Research, nor its parent, is registered as a securities broker-dealer or an investment adviser with FINRA or with any state securities regulatory authority.
ALL INFORMATION IN THIS BLOG, REPORT OR NEWSLETTER IS PROVIDED “AS IS” WITHOUT WARRANTIES, EXPRESSED OR IMPLIED, OR REPRESENTATIONS OF ANY KIND. TO THE FULLEST EXTENT PERMISSIBLE UNDER APPLICABLE LAW, TWO TRIANGLE CONSULTING GROUP, LLC WILL NOT BE LIABLE FOR THE QUALITY, ACCURACY, COMPLETENESS, RELIABILITY OR TIMELINESS OF THIS INFORMATION, OR FOR ANY DIRECT, INDIRECT, CONSEQUENTIAL, INCIDENTAL, SPECIAL OR PUNITIVE DAMAGES THAT MAY ARISE OUT OF THE USE OF THIS INFORMATION BY YOU OR ANYONE ELSE (INCLUDING, BUT NOT LIMITED TO, LOST PROFITS, LOSS OF OPPORTUNITIES, TRADING LOSSES, AND DAMAGES THAT MAY RESULT FROM ANY INACCURACY OR INCOMPLETENESS OF THIS INFORMATION). TO THE FULLEST EXTENT PERMITTED BY LAW, TWO TRIANGLE CONSULTING GROUP, LLC WILL NOT BE LIABLE TO YOU OR ANYONE ELSE UNDER ANY TORT, CONTRACT, NEGLIGENCE, STRICT LIABILITY, PRODUCTS LIABILITY, OR OTHER THEORY WITH RESPECT TO THIS PRESENTATION OF INFORMATION.
For more information, visit our Disclaimer: www.goldmanresearch.com